These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
386 related articles for article (PubMed ID: 8195509)
21. Limitations and late complications of third-generation automatic cardioverter-defibrillators. Nunain SO; Roelke M; Trouton T; Osswald S; Kim YH; Sosa-Suarez G; Brooks DR; McGovern B; Guy M; Torchiana DF Circulation; 1995 Apr; 91(8):2204-13. PubMed ID: 7697850 [TBL] [Abstract][Full Text] [Related]
22. Marked attenuation of shock burden by the use of antitachycardia pacing therapy in a patient with an implanted cardioverter-defibrillator. Ganjehei L; Nazeri A; Massumi A; Razavi M Tex Heart Inst J; 2012; 39(4):568-70. PubMed ID: 22949781 [TBL] [Abstract][Full Text] [Related]
23. Efficacy of automatic multimodal device therapy for ventricular tachyarrhythmias as delivered by a new implantable pacing cardioverter-defibrillator. Results of a European multicenter study of 102 implants. Fromer M; Brachmann J; Block M; Siebels J; Hoffmann E; Almendral J; Ohm OJ; den Dulk K; Coumel P; Camm AJ Circulation; 1992 Aug; 86(2):363-74. PubMed ID: 1638705 [TBL] [Abstract][Full Text] [Related]
24. Paced beats following single nonsensed complexes in a "codependent" cardioverter defibrillator and bradycardia pacing system: potential for ventricular tachycardia induction. Callans DJ; Hook BG; Marchlinski FE Pacing Clin Electrophysiol; 1991 Aug; 14(8):1281-7. PubMed ID: 1719506 [TBL] [Abstract][Full Text] [Related]
26. Subcutaneous Implantable Cardioverter Defibrillator Lead Repositioning for Preventing Inappropriate Shocks Due to Myopotential Oversensing in a Post-Fulminant Myocarditis Patient. Sasaki T; Nakamura K; Naito S Int Heart J; 2019 Mar; 60(2):466-469. PubMed ID: 30745542 [TBL] [Abstract][Full Text] [Related]
27. Inappropriate discharge of an implantable cardioverter defibrillator during atrial flutter and intermittent ventricular antibradycardia pacing. Peters W; Kowallik P; Wittenberg G; Scholl C; Meesmann M J Cardiovasc Electrophysiol; 1997 Oct; 8(10):1167-74. PubMed ID: 9363821 [TBL] [Abstract][Full Text] [Related]
28. Incidence of myopotential induction in subcutaneous implantable cardioverter-defibrillator patients: Is the oversensing issue really solved? van den Bruck JH; Sultan A; Plenge T; Seuthe K; Mödder T; Iliadis C; Stern D; Blankenheim T; Steven D; Lüker J Heart Rhythm; 2019 Oct; 16(10):1523-1530. PubMed ID: 31048064 [TBL] [Abstract][Full Text] [Related]
29. The pacer-cardioverter-defibrillator: function and clinical experience. Friedman PA; Stanton MS J Cardiovasc Electrophysiol; 1995 Jan; 6(1):48-68. PubMed ID: 7743010 [TBL] [Abstract][Full Text] [Related]
30. Decrease in amplitude of intracardiac ventricular electrogram and inappropriate therapy in patients with an implantable cardioverter defibrillator. Watanabe H; Chinushi M; Izumi D; Sato A; Okada S; Okamura K; Komura S; Hosaka Y; Furushima H; Washizuka T; Aizawa Y Int Heart J; 2006 May; 47(3):363-70. PubMed ID: 16823242 [TBL] [Abstract][Full Text] [Related]
32. Multiple shocks after upgrade of an implantable cardioverter-defibrillator to a cardiac resynchronization therapy-defibrillator device. Francisco GM; Sharma S; Dougherty AH; Kantharia BK Cardiol J; 2009; 16(5):473-6. PubMed ID: 19753529 [TBL] [Abstract][Full Text] [Related]
33. Clinical experience with antitachycardia pacing and improved detection algorithms in a new implantable cardioverter-defibrillator. Wietholt D; Block M; Isbruch F; Böcker D; Borggrefe M; Shenasa M; Breithardt G J Am Coll Cardiol; 1993 Mar; 21(4):885-94. PubMed ID: 8185728 [TBL] [Abstract][Full Text] [Related]
34. Oversensing issues leading to device extraction: When subcutaneous implantable cardioverter-defibrillator reached a dead-end. Noel A; Ploux S; Bulliard S; Strik M; Haeberlin A; Welte N; Marchand H; Klotz N; Ritter P; Haïssaguerre M; Bordachar P Heart Rhythm; 2020 Jan; 17(1):66-74. PubMed ID: 31295585 [TBL] [Abstract][Full Text] [Related]
35. A single implantable cardioverter-defibrillator shock unmasking an electrical storm of 389 ventricular tachycardia episodes triggering device therapies. Arias MA; Valverde I; Puchol A; Castellanos E; Rodríguez-Padial L; Sánchez AM; Alvarez-Temiño M; Palomino M Am J Emerg Med; 2008 Nov; 26(9):1066.e1-3. PubMed ID: 19091283 [TBL] [Abstract][Full Text] [Related]
36. Inappropriate discharges of intravenous implantable cardioverter defibrillators owing to lead failure. Washizuka T; Chinushi M; Kazama R; Hirono T; Watanabe H; Komura S; Sugiura H; Tanabe Y; Furushima H; Fujita S; Okura Y; Aizawa Y Int Heart J; 2005 Sep; 46(5):909-13. PubMed ID: 16272782 [TBL] [Abstract][Full Text] [Related]
37. T-wave oversensing and inappropriate shocks: a case report. Srivathsan K; Scott LR; Altemose GT Europace; 2008 May; 10(5):552-5. PubMed ID: 18442965 [TBL] [Abstract][Full Text] [Related]
38. Emergencies related to implantable cardioverter-defibrillators. Pinski SL Crit Care Med; 2000 Oct; 28(10 Suppl):N174-80. PubMed ID: 11055688 [TBL] [Abstract][Full Text] [Related]
39. Multiple appropriate and spurious defibrillator shocks in a patient with right ventricular cardiomyopathy. Strohmer B; Schernthaner C; Pichler M Int J Cardiol; 2005 Jul; 102(2):363-6. PubMed ID: 15982515 [TBL] [Abstract][Full Text] [Related]
40. Potential role of home monitoring to reduce inappropriate shocks in implantable cardioverter-defibrillator patients due to lead failure. Spencker S; Coban N; Koch L; Schirdewan A; Müller D Europace; 2009 Apr; 11(4):483-8. PubMed ID: 19103654 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]